Chris Ocampo

Head of Psychiatry, Neuroscience Clinical Development · AbbVie · company speakers →

I have been at AbbVie since 2013 having spent the majority of my time in Clinical Development across various therapeutic areas including Solid Tumor Oncology, Immunology, General Medicine/Virology and Neuroscience. Since joining the Neuroscience group in 2023 I have worked on assets in neurodegeneration and psychiatry and became Head of Psychiatry Clinical Development in 2025.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Neuropsychiatric Drug Development Summit

15 September 2026 Boston, United States “To What Degree Does Neuroplasticity Underpin Psychedelics Efficacy?”

Sourcing speakers for your event?

Browse the speaker directory →